Synovial Infiltration with CD79a-positive B Cells, But Not Other B Cell Lineage Markers, Correlates with Joint Destruction in Rheumatoid Arthritis

Ying‐Qian Mo, Lie Dai, Dong-Hui Zheng, Lang-Jing Zhu, Xiuning Wei, Frank Pessler, Jun Shen, Bai-Yu ZhangThe Journal of Rheumatology 2011 · DOI

TL;DR

This study reveals that a specific type of B cell, identified by the CD79a marker, is significantly elevated in the synovium of rheumatoid arthritis (RA) patients and strongly correlates with both disease activity and joint destruction. This finding suggests CD79a+ B cells could be a valuable biomarker for RA and play a direct role in the progression of joint damage.

What Problem Does This Paper Address?

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovitis (inflammation of the joint lining) that ultimately leads to joint destruction and disability. While B cells have been implicated in RA pathogenesis, particularly due to the success of B cell depletion therapies like rituximab (RTX), the precise role of different B cell subsets within the inflamed joint remains unclear. RTX effectively depletes circulating B cells, but its impact on synovial B cells is less pronounced, with some evidence suggesting that B cells expressing CD79a but not CD20 might persist and contribute to disease. This raises a critical question: which specific B cell populations in the synovium are most relevant to RA activity and joint damage, and can they serve as useful biomarkers?

Methods

The researchers employed immunohistochemical staining on synovial tissue biopsies from 69 RA patients, 14 osteoarthritis (OA) patients, and 15 patients with other orthopedic conditions (OrthA) serving as controls. They stained for various cell lineage markers, including CD79a (a pan-B cell marker present from early development to plasma cells), CD20 (mature B cells), CD38 (plasma cells), CD3 (T cells), CD68 (macrophages), CD34 (endothelial cells), and CD21 (follicular dendritic cells). The density of these stained cells was quantified and correlated with established measures of histologic disease activity (Krenn synovitis score) and radiographic joint destruction (Sharp score). Statistical analyses included receiver operating characteristic (ROC) curve analysis to assess diagnostic potential and Spearman's rank correlation to evaluate relationships between cell densities and clinical/radiographic outcomes.

Datasets

The study utilized synovial tissue samples from:

  • 69 Chinese patients with active Rheumatoid Arthritis (RA).
  • 14 patients with Osteoarthritis (OA).
  • 15 patients with orthopedic arthropathies (OrthA) as disease controls.

No new datasets or benchmarks were introduced; the study focused on analyzing existing patient samples.

Key Insights and Ideas

  • CD79a as a Key Player: The most striking finding is the strong association of CD79a-positive B cells with RA severity. Unlike CD20 or CD38, CD79a expression persists across a broader spectrum of B cell development, potentially capturing a more relevant population in the inflamed synovium.
  • Synovial B Cells Drive Destruction: The direct correlation between CD79a+ B cell density and radiographic measures of joint destruction (total Sharp score, erosion subscore, and joint space narrowing subscore) is a significant insight. This suggests these cells are not just bystanders but actively contribute to the structural damage in RA.
  • Biomarker Potential: The study strongly supports the idea that synovial CD79a+ B cells could serve as a valuable biomarker for both the current level of inflammation (synovitis score) and the extent of joint damage in RA.
  • Disease Duration Matters: CD79a+ B cell density was higher in patients with longstanding RA, further linking these cells to the chronic, progressive nature of the disease and joint destruction.

Key Results

  • Elevated CD79a+ Cells in RA: Synovial CD79a-positive cell density was significantly higher in RA patients compared to OA (p < 0.001) and OrthA (p = 0.003) controls.
  • Diagnostic Power: ROC analysis showed CD79a+ cell density effectively differentiated RA from OA (AUC = 0.79) and OrthA (AUC = 0.75).
  • Correlation with Synovitis: CD79a+ cell density showed a strong positive correlation with the Krenn synovitis score (r = 0.714, p < 0.001).
  • Correlation with Joint Destruction: CD79a+ cell density was significantly correlated with the total Sharp score (r = 0.490, p < 0.001), erosion subscore (r = 0.545, p < 0.001), and joint space narrowing subscore (r = 0.468, p = 0.001).
  • CD20 and CD38 Less Predictive: In contrast, CD20 and CD38 densities showed weaker or no significant correlations with joint destruction measures.
  • Longstanding RA: Patients with longstanding RA (> 2 years) had higher CD79a+ cell densities compared to those with early RA.

Limitations and Future Work

  • Cross-sectional Study: The study is cross-sectional, meaning it captures a single point in time. While correlations are shown, direct causation for joint destruction cannot be definitively proven without longitudinal studies.
  • Biopsy Location: Synovial biopsies were primarily from knee joints, while radiographic scores often evaluate small joints. The authors acknowledge that synovial inflammation in knee joints is generally comparable to that in small joints, but this remains a potential limitation.
  • Mechanism of Action: While the study identifies a correlation, the precise molecular mechanisms by which CD79a+ B cells contribute to joint destruction are not fully elucidated.
  • Future Directions: The authors suggest further investigation into the exact mechanisms by which CD79a-positive cells affect local inflammation and joint destruction. They also propose exploring the efficacy of anti-CD79 antibodies or siRNA silencing as potential therapeutic strategies.

Summary updated

Abstract

Synovial CD79a-positive B cells may be a helpful biomarker for histologic disease activity in RA and may be involved in the pathogenesis of joint destruction in RA.
BibTeX
@article{mo2011synovial,
  author = {Ying‐Qian Mo and Lie Dai and Dong-Hui Zheng and Lang-Jing Zhu and Xiuning Wei and Frank Pessler and Jun Shen and Bai-Yu Zhang},
  title = {{Synovial Infiltration with CD79a-positive B Cells, But Not Other B Cell Lineage Markers, Correlates with Joint Destruction in Rheumatoid Arthritis}},
  journal = {The Journal of Rheumatology},
  year = {2011},
  doi = {10.3899/jrheum.110615},
}
Figure